How Storage Conditions Change What Is in the Vial

Storage conditions change what is in the vial by driving slow chemical reactions in the peptide. Heat speeds them up. Oxygen, light and trace metals promote oxidation. Water allows hydrolysis and deamidation. Most of this does not change how the powder looks, so a vial that has degraded and a vial that has not can be indistinguishable by eye. The consequence is simple. A certificate describes a sample at the moment it was measured. It does not describe the vial after months of storage somewhere else.

This article sets out the main degradation pathways, what triggers each, how they appear in analytical data, and what a Certificate of Analysis can and cannot say about any of it.

Why peptides change at all

A peptide is a chain of amino acids joined by amide bonds. Each side chain has its own chemistry. Some are inert. Others are reactive under ordinary conditions. Degradation is the sum of those reactions over time, and the rate depends on the sequence, the physical state of the material and its surroundings.

Two points follow. First, no storage condition makes a peptide permanently unchanging. Second, the same storage condition can be harmless for one peptide and damaging for another. A sequence rich in methionine behaves differently from one without it. General rules are a starting point only.

The main degradation pathways

The common routes are well characterised in the chemistry literature. Each depends on specific residues.

• Deamidation. Asparagine, and to a lesser degree glutamine, loses its side-chain amide group. For asparagine the reaction usually runs through a cyclic succinimide intermediate, which then opens to aspartic acid or its isomer, isoaspartic acid. It is pH and temperature dependent, and it is fastest when the next residue is small and flexible, as in an Asn-Gly sequence. It can occur in solution and, more slowly, in the solid state.
• Oxidation. Methionine is the most commonly affected residue, forming methionine sulfoxide. Cysteine, tryptophan, histidine and tyrosine can also oxidise. Triggers include dissolved or headspace oxygen, light, and trace metal ions that catalyse the reaction. Cysteine oxidation is generally faster at higher pH.
• Hydrolysis and backbone cleavage. The peptide bond itself can break in the presence of water. Bonds next to aspartic acid are particularly susceptible, especially under acidic conditions. The result is two shorter fragments.
• Aggregation and dimerisation. Peptide molecules can associate into dimers or larger assemblies. Free cysteines can form intermolecular disulfide bonds. Some sequences aggregate through physical association without any covalent change.
• Diketopiperazine formation. The free N-terminal amine can attack the bond between the second and third residues, releasing the first two residues as a cyclic dipeptide. The remaining peptide is two residues shorter. It is most associated with proline or glycine near the N-terminus.
• Disulfide scrambling. In peptides with more than one disulfide bond, bonds can exchange partners under neutral to alkaline conditions or in the presence of free thiols. The mass is unchanged. The connectivity, and often the shape, is not.
• Beta-elimination. Under alkaline conditions, cysteine and some other residues can lose a side-chain group, forming dehydroalanine. This reactive product can go on to form crosslinks.
• Pyroglutamate formation. An N-terminal glutamine can cyclise, losing ammonia. It is a common modification of that residue.

Not every peptide is exposed to every pathway. A short sequence with no methionine, cysteine, asparagine or glutamine has far fewer routes available than a long one that contains all four.

The dry state, and why moisture still matters

Most peptides are supplied lyophilised, meaning freeze-dried. Water is removed by sublimation under vacuum, leaving a porous solid. Many degradation reactions need water as a reactant or as a medium that lets molecules move. With most of it removed, those reactions slow considerably. This is the reason dry powder is generally more stable than the same peptide in solution.

The word generally matters. Lyophilised material is not inert. Some reactions, including solid-state deamidation, continue in the dry cake. And the powder is rarely perfectly dry.

A lyophilised peptide retains some water, and it is hygroscopic, so it can take up more from humid air. Residual moisture acts as a plasticiser. It increases molecular mobility in the solid and can restart reactions that dry conditions had suppressed. A vial opened repeatedly in a humid room, or a poorly sealed closure, lets moisture in.

Water content is measured by Karl Fischer titration. That measurement is covered in the article on Karl Fischer water content. It reports how much water was in the sample at the time of testing. It does not predict how much will be there after storage, and it does not show whether degradation has already happened.

Temperature and freeze-thaw cycles

Chemical reaction rates fall as temperature falls. A refrigerator slows degradation relative to room temperature. A freezer at -20C or -80C slows it further. This is why cold storage is the standard recommendation, with the fridge usually described as suitable for short periods and the freezer for long periods.

Cold slows degradation. It does not stop it. A peptide held at -20C for a long enough time can still change, particularly if it holds moisture or reactive residues. Low temperature is a rate modifier, not a preservative in any absolute sense.

Freeze-thaw cycling is a separate problem, and it applies mainly to solutions. As water freezes, solutes concentrate in the remaining liquid. This can shift pH locally, raise peptide concentration and promote aggregation. Repeated cycles compound the effect. The usual practice with reconstituted material is to avoid cycling it at all, for example by dividing a solution into single-use portions.

For dry powder there is a different hazard. A cold vial opened in a warm room draws condensation onto the powder. Allowing the sealed vial to reach room temperature first reduces that risk.

Light and oxygen

Oxidation needs an oxidant, and oxygen is the usual one. A vial with air in the headspace holds a supply. Light, particularly ultraviolet, can initiate photo-oxidation of tryptophan, tyrosine, histidine and methionine. Trace metal ions can catalyse oxidation even at very low concentrations.

Amber glass, opaque outer packaging and an inert gas headspace are common ways to limit these effects. Each reduces exposure. None removes it. Oxidation products are also, in some cases, difficult to reverse, so a peptide that has oxidised cannot be assumed to be recoverable.

Reconstituted peptides and bacteriostatic water

Dissolving a peptide changes its stability profile. Water is now abundant. Molecules move freely. Deamidation, hydrolysis, oxidation and aggregation all generally proceed faster than in the dry state. The pH of the solution matters a great deal, and different reactions prefer different pH ranges, so there is rarely one pH that suits every pathway.

Bacteriostatic water contains a preservative, usually benzyl alcohol, which inhibits bacterial growth in a multi-use vial. That addresses microbial contamination. It does not slow the chemical reactions described above. A solution can be microbiologically controlled and still be degrading.

No single shelf life applies to reconstituted peptides. It depends on the sequence, the concentration, the pH, the temperature and how often the vial is accessed. Any specific figure quoted without reference to a particular peptide and set of conditions should be treated cautiously.

How degradation shows up in the data

Degradation is detected by measurement, not by inspection. Two techniques carry most of the evidence.

HPLC. On a chromatogram, degradation products usually appear as new peaks or shoulders, often eluting slightly before or after the main peak. Because the area-percent purity is the main peak as a share of total peak area, new peaks reduce it. A purity that falls between two tests of the same material is a sign that something has changed. The wider topic of what those extra peaks are is covered in the article on peptide impurities.

Mass spectrometry. Many pathways leave a characteristic mass shift:

• Oxidation of methionine to the sulfoxide adds about 16 Da.
• Deamidation of asparagine or glutamine adds about 1 Da, more precisely 0.984 Da, which is small enough to be easily missed at low resolution.
• Formation of an intramolecular disulfide bond removes about 2 Da.
• Pyroglutamate formation from an N-terminal glutamine removes about 17 Da.
• Diketopiperazine formation gives a species lighter by the mass of the lost dipeptide.
• Hydrolysis produces two fragments whose masses sum to the parent plus water.

Some changes are invisible to one method. Disulfide scrambling leaves the mass unchanged. Deamidation can leave HPLC retention almost unaltered. Isoaspartate and aspartate share a mass. This is why a single technique cannot rule degradation out.

One point needs care. A change in net peptide content is not a degradation signal. Net peptide content reflects how much of the powder is peptide as opposed to water, counter-ions and other non-peptide material. A vial can take up moisture and show a lower net peptide content without any peptide having degraded. The two ideas are separate and should not be conflated.

What a certificate can and cannot say

A Certificate of Analysis reports what was measured in the sample submitted, at the time it was tested. It is a snapshot. It cannot speak to how the material was stored before it reached the laboratory, and it cannot speak to what happened to the vial after the result was issued. Two vials from one batch, stored differently, can diverge in composition over time.

This is not a flaw in the certificate. It is a property of any measurement. A result describes the sample at a point in time, and storage conditions between that measurement and the vial in someone's hand are outside the laboratory's knowledge.

It also means a certificate does not prove that a vial held today is the same as the one tested. It does not show that the material has remained within any specification. And a purity figure describes composition, not safety. A high measured purity says nothing about how a material will behave in use.

The related idea in pharmaceutical practice is the distinction between a retest date and an expiry date. A retest date marks when material should be re-examined to confirm it still meets requirements. An expiry date marks the end of the period for which a product is expected to remain within specification under stated storage conditions. The difference is set out in the article on retest date versus expiry. Both depend on defined storage conditions, which is exactly the information a one-off certificate does not carry.

Practical reading of a result

A few habits follow from the chemistry.

• Read the certificate date alongside the result. An old result says less about a vial today than a recent one.
• Treat storage history as part of the question. A cold, sealed, dry vial and a warm, repeatedly opened one are different materials after enough time.
• Do not read the absence of visible change as evidence of stability.
• If the material matters, retest it. A new measurement is the only way to learn what a vial contains now.

Novagen is a third-party analytical laboratory. It reports what was measured in the sample submitted, and it publishes a verifiable certificate register at novagenlaboratories.com, which can be checked through the verification page. A register entry confirms that a certificate exists and what it says. It does not confirm anything about the vial after that date. Current quoted turnaround is 21 days from receipt of samples. Questions can be sent to admin@novagenlaboratories.com. For the broader picture of what testing does and does not establish, see the overview of peptide testing.